Targeting lung fibrosis in mice
Author Information
Author(s): Adrian Fischer, Wei Han, Shaoping Hu, Martin Mück-Häusl, Juliane Wannemacher, Safwen Kadri, Yue Lin, Ruoxuan Dai, Simon Christ, Yiqun Su, Bikram Dasgupta, Aydan Sardogan, Christoph Deisenhofer, Subhasree Dutta, Amal Kadri, Gökhan Tankut Güney, Donovan Correa-Gallegos, Christoph H. Mayr, Rudolf Hatz, Mircea Gabriel Stoleriu, Michael Lindner, Anne Hilgendorff, Heiko Adler, Hans-Günther Machens, Herbert B. Schiller, Stefanie M. Hauck, Yuval Rinkevich
Primary Institution: Helmholtz Zentrum München, Munich, Germany
Hypothesis
Can targeting pleuro-alveolar junctions reverse lung fibrosis?
Conclusion
Targeting the disassembly of pleuro-alveolar junctions can reverse chronic lung fibrosis in mice.
Supporting Evidence
- Alveolar macrophages play a key role in the development of lung fibrosis.
- Targeting the pleuro-alveolar junctions can prevent the progression of fibrosis.
- Therapeutic interventions that inhibit matrix disassembly can reverse established fibrosis.
Takeaway
This study shows that a specific part of the lung can be targeted to help fix lung scarring in mice, which could help people with similar problems.
Methodology
The study used fate mapping and various animal models to track the movement of extracellular matrix in lung fibrosis.
Potential Biases
Potential bias in the interpretation of animal model results as they may not fully represent human disease.
Limitations
The study's findings may not fully translate to human conditions, and the specific markers for pleuro-alveolar junctions need further research.
Statistical Information
P-Value
0.00013
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website